Delta Investment Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Delta Investment Management's BMY Position: Q1 2026 in Review
Delta Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 6% in Q1 2026, selling an estimated $14.9K and leaving 3,988 shares worth $242K. The position accounts for 0.04% of the portfolio, ranked #235.
Delta Investment Management first reported a position in BMY in Q2 2019 and has held it in 25 quarters since. The position peaked at $362K in Q4 2019. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Delta Investment Management held 3,988 shares of Bristol-Myers Squibb worth $242K as of Q1 2026.
- Delta Investment Management sold 256 Bristol-Myers Squibb shares in Q1 2026, an estimated $14.9K.
- Bristol-Myers Squibb made up 0.04% of Delta Investment Management's portfolio in Q1 2026, its #235 holding.
- Delta Investment Management first reported a position in Bristol-Myers Squibb in Q2 2019 and has held it in 25 quarters since.
- Delta Investment Management's Bristol-Myers Squibb position peaked at $362K in Q4 2019.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Delta Investment Management's 13F filing for Q1 2026, filed 13 May 2026.